BJL
WST icon

Brighton Jones LLC’s West Pharmaceutical WST Stock Holding History

Brighton Jones LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+594
New +$182K ﹤0.01% 1225
2025
Q4 		– Sell
-2,514
Closed -$660K – 980
2025
Q3 		$660K Buy
+2,514
New +$611K 0.02% 531

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Brighton Jones LLC's WST Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in West Pharmaceutical (WST) in Q2 2026: 594 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #1225 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in WST as recently as Q3 2025.

Brighton Jones LLC first reported a position in WST in Q3 2025 and has held it in 2 quarters since. The position peaked at $660K in Q3 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Brighton Jones LLC held 594 shares of West Pharmaceutical worth $213K as of Q2 2026.
  • West Pharmaceutical was a new Brighton Jones LLC position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1225 holding.
  • Brighton Jones LLC first reported a position in West Pharmaceutical in Q3 2025 and has held it in 2 quarters since.
  • Brighton Jones LLC's West Pharmaceutical position peaked at $660K in Q3 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.